"aurobindo-pharma"

This year's edition to be held virtually

The company has received final approval from USFDA to manufacture and market Droxidopa capsules in the strengths of 100 mg, 200 mg and 300 mg

Lupin is recalling 46,479 bottles of anti-viral medication Oseltamivir Phosphate for Oral Suspension.

Hyderabad company's arms Lyfius and Qule Pharma to set up three facilities with Rs 3,039 cr.

As per the USFDA, Marksans Pharma is recalling close to six lakh bottles of diabetes drug Metformin Hydrochloride extended-release tablets in strengths of 500 mg and 750 mg in the US market

The all-cash transaction which is valued at $550 million (4,048 crore) is expected to close by January 2021

AuroLife Pharma, a wholly-owned step-down subsidiary of the company, has received a warning letter from the United States Food and Drug Administration (USFDA) for its oral solid manufacturing facility situated at Dayton